NCT04613271, 0 NCT04613271
azithromycin vs. azithromycin
COVID-19 mild to moderate
Espitia-Hernandez, 2020
azithromycin vs. standard of care
COVID-19 mild to moderate
Rashad A (AZI vs SoC), 2021
azithromycin vs. standard of care
COVID-19 mild to moderate
COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 NCT04322123
azithromycin vs. standard of care
COVID-19 mild to moderate
Coalition Covid-19 Brazil I (Cavalcanti) - HCQ AZI, 2020 NCT04322123
azithromycin plus hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Ren, 2020 ChiCTR2000029853
azvudine vs. antiviral and associated therapy
COVID-19 mild to moderate
Li T, 2020 NCT04273763
bromhexine vs. standard of care
COVID-19 mild to moderate
NCT04342650, 2020 NCT04342650
chloroquine vs. placebo
COVID-19 mild to moderate
Thakar, 2021
chloroquine vs. standard of care
COVID-19 mild to moderate
CloroCOVID19II, 0 NCT04342650
chloroquine and derivatives vs. placebo
COVID-19 mild to moderate
Asan Medical Center (chloroquine), 0 NCT04307693
chloroquine and derivatives vs. standard of care
COVID-19 mild to moderate
Spoorthi, 2020
doxycycline vs. placebo
COVID-19 mild to moderate
Mukae - Phase 2a, 2022 jRCT2031210350
Ensitrelvir (XOCOVA) vs. placebo
COVID-19 mild to moderate
NCT04613271, 0 NCT04613271
favipiravir vs. azithromycin
COVID-19 mild to moderate
Dabbous, 2021 NCT04351295
favipiravir vs. chloroquine
COVID-19 mild to moderate
CTRI/2020/06/025957, 0 CTRI/2020/06/025957
favipiravir vs. favipiravir
COVID-19 mild to moderate
IRCT20201005048936N1, 0 IRCT20201005048936N1
favipiravir vs. hydroxychloroquine
COVID-19 mild to moderate
Solaymani-Dodaran, 2021 IRCT20200318046812N1
favipiravir vs. lopinavir/ritonavir
COVID-19 mild to moderate
IRCT20151227025726N14 // U07, 0 IRCT20151227025726N1
favipiravir vs. lopinavir/ritonavir
COVID-19 mild to moderate
Hassaniazad, 2020 IRCT20200506047323N3
favipiravir vs. lopinavir/ritonavir plus interferon ß-1a
COVID-19 mild to moderate
NCT04600895, 0 NCT04600895
favipiravir vs. placebo
COVID-19 mild to moderate
Shinkai, 2021 JapicCTI-205238
favipiravir vs. placebo
COVID-19 mild to moderate
EUCTR2020-001608-40-DE, 0 EUCTR2020-001608-40-
favipiravir vs. placebo
COVID-19 mild to moderate
NCT04464408, 0 NCT04464408
favipiravir vs. placebo
COVID-19 mild to moderate
Holubar M, 2021 NCT04346628
favipiravir vs. placebo
COVID-19 mild to moderate
Shenoy S, 2021 NCT04529499
favipiravir vs. placebo
COVID-19 mild to moderate
NCT04336904, 0 NCT04336904
favipiravir vs. placebo
COVID-19 mild to moderate
FACCT Trial, 2021 NCT04392973
favipiravir vs. standard of care
COVID-19 mild to moderate
Ruzhentsova T, 2020 NCT04501783
favipiravir vs. standard of care
COVID-19 mild to moderate
Udwadia, 2020 CTRI/2020/05/025114
favipiravir vs. standard of care
COVID-19 mild to moderate
GETAFIX, 2020 ISRCTN31062548
favipiravir vs. standard of care
COVID-19 mild to moderate
Dabbous HM, 2020 NCT04349241
favipiravir vs. standard of care
COVID-19 mild to moderate
AVIFAVIR, 2020 NCT04434248
favipiravir vs. standard of care
COVID-19 mild to moderate
NCT04600999, 0 NCT04600999
favipiravir vs. standard of care
COVID-19 mild to moderate
NCT04542694, 2020 NCT04542694
favipiravir vs. standard of care
COVID-19 mild to moderate
Khamis, 2020
favipiravir plus interferon vs. standard of care
COVID-19 mild to moderate
NCT04668950, 0 NCT04668950
fluvoxamine vs. placebo
COVID-19 mild to moderate
EUCTR2020-002299-11, 0 EUCTR2020-002299-11
fluvoxamine vs. placebo
COVID-19 mild to moderate
Min, 2020
hydroxychloroquine vs. control
COVID-19 mild to moderate
Fteiha, 2020
hydroxychloroquine vs. control
COVID-19 mild to moderate
Dubee, 2021
hydroxychloroquine vs. placebo
COVID-19 mild to moderate
NCT04333654, 2020 NCT04333654
hydroxychloroquine vs. placebo
COVID-19 mild to moderate
COV-HCQ, 2020 NCT04342221
hydroxychloroquine vs. placebo
COVID-19 mild to moderate
HC-nCoV (Shanghai), 2020 NCT04261517
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Zhaowei Chen, 2020 ChiCTR2000029559
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
FACCT Trial, 2021 NCT04392973
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Kamran, 2020 NCT04491994
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
Coalition Covid-19 Brazil I (Cavalcanti)-Hydroxychloroquine, 2020 NCT04322123
hydroxychloroquine vs. standard of care
COVID-19 mild to moderate
COVIDOC, 0 NCT04345861
hydroxychloroquine plus macrolides vs. chloroquine and derivatives
COVID-19 mild to moderate
AZIQUINE-ICU (A plus HCQ), 0 NCT04339816
hydroxychloroquine plus macrolides vs. placebo
COVID-19 mild to moderate
Mayer, 2022
ivermectin vs. control
COVID-19 mild to moderate
Abd-Elsalam, 2021 NCT04403555
ivermectin vs. control
COVID-19 mild to moderate
Babalola, 2021
ivermectin vs. lopinavir/ritonavir
COVID-19 mild to moderate
SINZ-COVID-PK, 2020 NCT04472585
ivermectin vs. placebo
COVID-19 mild to moderate
Kirti, 2021 CTRI/2020/08/027225
ivermectin vs. placebo
COVID-19 mild to moderate
Spoorthi, 2020
ivermectin vs. placebo
COVID-19 mild to moderate
Ahmed, 2020
ivermectin vs. placebo
COVID-19 mild to moderate
RIVET-COV (Mohan) (12mg and 24mg), 2021 CTRI/2020/06/026001
ivermectin vs. placebo
COVID-19 mild to moderate
Chaccour, 2020 NCT04390022
ivermectin vs. placebo
COVID-19 mild to moderate
Glorial F, 2020 NCT04343092
ivermectin vs. standard of care
COVID-19 mild to moderate
IFORS (Pott-Junior), 2020 NCT04431466
ivermectin vs. standard of care
COVID-19 mild to moderate
Espitia-Hernandez, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
I-TECH (Lim), 2022 NCT04920942
ivermectin vs. standard of care
COVID-19 mild to moderate
Khan, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Bukhari, 2021 NCT04392713
ivermectin vs. standard of care
COVID-19 mild to moderate
Shahbaznejad, 2020 IRCT20111224008507N3
ivermectin vs. standard of care
COVID-19 mild to moderate
Soto-Becerra, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Nasir, 2020
ivermectin vs. standard of care
COVID-19 mild to moderate
Chachar, 2020 NCT04739410
ivermectin vs. standard of care
COVID-19 mild to moderate
Krolewiecki, 2020 NCT004381884
ivermectin vs. standard of care
COVID-19 mild to moderate
NCT04523831 (Mahmud), 2020 NCT04523831
ivermectin plus doxycycline vs. standard of care
COVID-19 mild to moderate
NCT04343651, 0 NCT04343651
leronlimab vs. placebo
COVID-19 mild to moderate
Asan Medical Center (lopinavir/ritonavir), 0 NCT04307693
lopinavir/ritonavir vs. standard of care
COVID-19 mild to moderate
ELACOI (lopinavir/ritonavir), 2020 NCT04252885
lopinavir/ritonavir vs. standard of care
COVID-19 mild to moderate
Hung et al., 2020 NCT04276688
lopinavir/ritonavir, ribavirin and interferon beta-1b vs. lopinavir/ritonavir
COVID-19 mild to moderate
Silva, 2021 NCT04463264
nitazoxanide vs. placebo
COVID-19 mild to moderate
Rocco, 2020 NCT04552483
nitazoxanide vs. placebo
COVID-19 mild to moderate
Fontanesi, 2021 NCT04348409
nitazoxanide vs. placebo
COVID-19 mild to moderate
GS-US-540-5773 (Goldman), 2020 NCT04292899
remdesivir vs. remdesivir
COVID-19 mild to moderate
GS-US-540-5774, 10 days, 2020 NCT04292730
remdesivir vs. standard of care
COVID-19 mild to moderate
GS-US-540-5774, 5 days, 2020 NCT04292730
remdesivir vs. standard of care
COVID-19 mild to moderate
Nourian A, 2020 IRCT20100228003449
sofosbuvir and ledipasvir vs. standard of care
COVID-19 mild to moderate
CTRI/2020/06/025957, 0 CTRI/2020/06/025957
umifenovir (arbidol) vs. favipiravir
COVID-19 mild to moderate
ELACOI (Lopinavir/ritonavir), 2020 NCT04252885
umifenovir (arbidol) vs. lopinavir/ritonavir
COVID-19 mild to moderate
Yethindra, 2020 None
umifenovir (arbidol) vs. standard of care
COVID-19 mild to moderate